The explosion in the use of costly GLP-1 drugs has helped fuel a 9.3% jump in per-person drug costs for CT residents.

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...

Novo Nordisk trades at a significant discount to Eli Lilly, offering nearly 38% upside. Click here to find out why NVO stock ...

It isn’t uncommon for insurance premiums to rise annually, but the statewide average of 28% is notably higher than the increase in years past: 5.6% in 2025, 9.7% in 2024, 10.4% in 2023 and 1.1% in ...

Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...

New Jersey’s public health insurance system is hemorrhaging. We're about to feel the pain. Public workers and taxpayers deserve better.

Discover Fulton County's latest budget updates, health initiatives, and a proposed public health levy to secure vital services into the future.

New permanent tax exclusions and expanded funds usage give benefit leaders the opportunity to bolster their financial ...

A student from BITS Pilani Hyderabad has developed a smartwatch-based wearable that non-invasively measures blood glucose levels using sweat.